To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill provides federal Trade Commission enforcement against sham petitions and requires severability If any provision of this Act or the application of such provision to any person or circumstance is held to be unconstitutional, the remainder of this Act and the application of the provisions. It relies on compliance mandates, definition changes, appropriations, and reporting requirements. The main policy areas are Healthcare Consumers, Healthcare, Finance, and Environment.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens, Businesses and employers affected by the bill could face lower compliance burdens, and Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Public beneficiaries or protected communities affected by the clause could face increased risk.
Key Provisions
- Provides federal Trade Commission enforcement against sham petitions.
- Requires severability If any provision of this Act or the application of such provision to any person or circumstance is held to be unconstitutional, the remainder of this Act and the application of the provisions...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill provides federal Trade Commission enforcement against sham petitions and requires severability If any provision of this Act or the application of such provision to any person or circumstance is held to be unconstitutional, the remainder of this Act and the application of the provisions.
Key Policy Areas
Healthcare Consumers, Healthcare, Finance, Environment
Primary Purpose
The bill provides federal Trade Commission enforcement against sham petitions and requires severability If any provision of this Act or the application of such provision to any person or circumstance is held to be unconstitutional, the remainder of this Act and the application of the provisions.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Businesses and employers affected by the bill
- Public beneficiaries or protected communities affected by the clause
- Environmental and public health interests affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Public beneficiaries or protected communities affected by the clause
Sponsors
Legislative Progress
IntroducedMs. Klobuchar (for herself, Mr. Grassley, Mr. Durbin, Mr. Braun, …
Ms. Klobuchar (for herself, Mr. Grassley, Mr. Durbin, Mr. Braun, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology